Rating History for Allovir Inc. (ALVR) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/22/2023 | Michael Ulz | Downgrade | Equalweight (Overweight) |
1.00 (20.00) |
2.33 (9.81) |
321.03% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/22/2023 | Michael Ulz | Downgrade | Equalweight (Overweight) |
1.00 (20.00) |
2.33 (9.81) |
321.03% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||